Home › Attention Deficit Hyperactivity Disorder › Arkansas
Attention Deficit Hyperactivity Disorder clinical trials in Arkansas
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Arkansas.
Cities in Arkansas
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Preferred Research Partners, Inc., Little Rock
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Little Rock
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Little Rock
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
- University of Arkansas, Fayetteville
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated May 27, 2026 · NCT06115603From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.